Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

NCT01131104 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01131104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01131104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Lead sponsor
Eli Lilly and Company
Phase
Observational
Overall status
Completed
Start date
May 31, 2010
Completion date
December 31, 2015
Enrollment
345 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

nonarteritic anterior ischemic optic neuropathy